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Abstract
It is suspected that bone marrow (BM) microenvironmental factors may influence the evolution of chronic myeloid
leukaemia (CML). In this study, we postulated that adipocytes and lipids could be involved in the progression of CML. To
test this hypothesis, adipocytes were co-cultured with two BCR-ABL positive cell lines (PCMDS and K562). T cell (Jurkat) and
stroma cell (HS-5) lines were used as controls. In the second set of experiments, leukemic cell lines were treated with stearic,
oleic, linoleic or a-linolenic acids in presence or absence of leptin. Survival, proliferation, leptin production, OB-R isoforms
(OB-Ra and OB-Rb), phosphoinositide 3-kinase (PI3k) and BCL-2 expression have been tested after 24h, 48h and 72h of
treatment. Our results showed that adipocytes induced a decrease of CML proliferation and an increase in lipid
accumulation in leukemic cells. In addition, CML cell lines induced adipocytes cell death. Chromatography analysis showed
that BM microenvironment cells were full of saturated (SFA) and monounsaturated (MUFA) fatty acids, fatty acids that
protect tumor cells against external agents. Stearic acid increased Bcl-2 expression in PCMDS, whereas oleic and linoleic
acids had no effects. In contrast, a-linolenic acid decreased the proliferation and the survival of CML cell lines as well as BCL-
2 and OB-R expression. The effect of a-linolenic acids seemed to be due to PI3K pathway and Bcl-2 inhibition. Leptin
production was detected in the co-culture medium. In the presence of leptin, the effect of a-linolenic acid on proliferation,
survival, OB-R and BCl-2 expression was reduced.
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Introduction
Chronic myelogenous leukemia (CML) is a malignant disorder
of the hematopoietic stem cell (HSC) characterized by a reciprocal
translocation between chromosomes 9 and 22 (t(9;22)(q34;q11))
[1]. The translocation results in formation of the BCR-ABL fusion
oncogene encoding a protein with constitutive tyrosine kinase
activation, which plays a central role in the pathogenesis of the
disease. Many mechanisms are involved in the malignant
transformation orchestrated by the BCR-ABL oncoprotein [2].
It constitutively activates mitogenic signaling pathways such as the
phosphoinositide-3 (PI3) kinase pathway [3]. Once activated, the
PI3K controls cell growth, proliferation and apoptosis, as well as
steps that are involved in tumor formation and malignant cell
dissemination [4].
Although abnormal leukemic cells define the tumor compart-
ment itself, environmental factors could participate in the
evolution of the disease. Indeed, alterations in the bone marrow
microenvironment were widely described. These alterations
include deregulated patterns of cytokine production that promoted
a proinflammatory environment. These alterations induce a
deficient of hematopoietic supportive capacity and decreased the
number of cells in certain stromal cell populations [5].
In addition: 1) Some reports suggest that obesity play important
role in CML risk [6–7]. ; 2) Morphologically identifiable adipo-
cytes, the most abundant bone marrow stromal cells in healthy
adult [8–9], were shown to inhibit myeloid differenciation [10,11].
In patient with CML, the number of pre-adipocytes increased
during the chronic phase and was reduced once CML entered
blast phase [12]. At remission, there is a recurrence of bone
marrow (BM) adipocytes [13]. ; 3) In certain cases of leukemia, a
shift of low density lipoprotein (LDL) from blood to spleen, liver
and bone marrow was observed [14–15]. At the remission, LDL in
peripheral blood return to normal values.A drop in saturated and
monounsaturated fatty acids in the bone marrow was also
described in leukemic patient [16,17]. The involvement of fatty
acids has been widely demonstrated in some cancers such as breast
cancer [18–19] but has never been studied in CML. ; 4) Genes
coding for the receptor of leptin (OB-R), an adipokine produced
predominantly by adipocytes [8,20], and for proteins involved in
fatty acid synthesis, were upregulated in CML cells [3]. This
upregulation was directly associated with activation of the PI3K
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signaling pathway, the major signalling pathway of OB-R [21],
involved in drug resistance [22]. ; 5) Despite many studies
demonstrating the protective effects of leptin against acute myeloid
leukemia (AML) [20,23], the role of leptin in CML remains
unclear. CML seems to be resistant to the proliferative effects of
leptin [20].
Lipid accumulation in the BM associated with OB-R expression
and PI3K/AKT signalling activation led us to believe that fat cells
and lipids could be involved in the evolution of the disease. In this
work, we studied the possible role of adipocytes, leptin and fatty
acids in the CML disease progression by analysing interactions
between BM adipocytes and BCR-ABL positive cell lines and
exploring the potential effects of leptin and fatty acids on these cell
lines.
Materials and Methods
Isolation and culture of adipocytes
Femoral and iliac crest bone marrow (BM) samples were
obtained from patients undergoing hip surgery at the Department
of Orthopedic Surgery (CHR, Lie`ge, Belgium). The hospital ethics
committee of the University of Lie`ge (B70720095686-2009/26)
approved this study and the donors were informed by written
consent in accordance with the Helsinki convention. Adipocytes
were isolated from femoral biopsies and cultured as previously
described [10]: briefly, after dissociation with collagenase, floating
adipocytes were cultured using the ceiling method. They were
amplified in a long-term culture medium (alpha-MEM, 12.5%
horse serum, 12.5% fetal calf serum, 2mM L-glutamax, 0.2M
inositol, 100 M ß-mercaptoethanol, 50 U/ml penicillin and
50 mg/ml streptomycin). Adipocytes from BM acquired a
fibroblast-like fat cell (FLFC) morphology in vitro but conserved
the typical features of freshly isolated BM adipocytes [10].
Cell lines
PCMDS cell line, was described as CML [24] and kindly
provided by Dr G.Bogdanovic (Sremska Kamenica Oncology
Institute, Serbia). A stromal cell line (HS-5), the CML cell line
K562 and a T cell line (Jurkat) were purchased from American
Type Culture Collection (ATCC Rockville, MD). Cell lines were
maintained in RPMI-1640 medium containing 10% fetal calf
serum, 1% L-glutamine, 50 U/ml penicillin and 50 mg/ml
streptomycin.
Co-cultures of leukemic cells with FLFCs or HS-5
FLFCs or HS-5 were plated in 6- or 96-well plates at 1006103
or 306103 cells, respectively. After monolayers formation, 56103
(96-well plates) or 306103 (6-well plates) PCMDS, K562 or Jurkat
cells were added either in cell-cell contact or using transwell
chamber (cell culture insert 8 mm pore size PET track-etched
membrane, Becton Dickinson, France). For [3H]Thymidine
experiments, FLFCs and HS-5 monolayers were irradiated before
the addition of 106103 PCMDS. Cultures were stopped after 24h,
48h and one week. Conditioned media were collected and stored
at 280uC until dosage of leptin by enzyme-linked immunosorbent
assay (ELISA)(R&D Systems Inc, France). Leukemic cells were
used for morphological analysis, immunostaining, protein and
RNA extraction.
Fatty acid stimulation
For lipid stimulation, PCMDS, K562 or Jurkat cell line (256103
/ml) were cultured in the presence of 50 to 250 mM of stearic
(C18:0), oleic (C18:1), linoleic (C18:2 n-6) or a-linolenic acids
(C18:3 n-3) (all from Sigma-Aldricht, France) with or without
addition of 400 mg/ml of a-Tocopherol (Sigma-Aldricht, France).
Oil Red O staining
Cytospins were realized for Oil Red O staining : they were fixed
in formaldehyde vapor during 5 min, stained with Oil-Red-O
(Sigma-Aldricht, France) for 10 min, air-dried and counterstained
with hematoxylin for 5 min.
Flow cytometry
Flow cytometry analysis were performed on a FACS-CantoII
(Becton Dickinson and Company, France). Cell suspensions were
incubated with a mouse anti-OBR (R&D Systems, France)
antibody (1/50) for one hour at room temperature, then with a
FITC conjugated rat anti-mouse (IgG2b) antibody (1/400) (BD
biosciences, France).
[3H]Thymidine uptake
After 24h or 48h of co-culture, 0.1 mCi of [3H]Thymidine
(specific activity, 6.7 Ci/mmol), (DuPont, Wilmington, DE) was
added to the medium for 6 hours. The cell suspensions were then
deposited onto harvester filters using a semiautomatic cell
harverster (unifilter 96 haverster, Perkinelmer, USA). Radioactiv-
ity was measured using a scintillation counter (Topcount,
Perkinelmer, USA) and expressed as counts per minute (CPM).
Apoptosis
To quantify apoptosis, the cells were analyzed over time by
staining for the phosphatidylserine translocation using FITC-
annexin V and propidium iodide (PI) (Annexin-V/PI kit, BD
Pharmingen, USA), according to the manufacturer’s instructions.
Samples were analysed on a FACS CantoII (Becton Dickinson,
France).
Fatty acids analysis
Total lipids were extracted from femoral bone marrow with
chloroform-methanol 2:1 (v:v) as previuosly described Folch et al
[25]. The extract was concentrated under reduce pressure at
35uC. Fatty acid methyl esters (FAME) were prepared from crude
lipids by Boron trifluoride catalyzed transesterification. Ten mg
lipids were dissolved in 0.5 ml n-hexane to which 0.5 ml of
reagent (14% BF3-methanol, dry methanol and n-hexane
25:55:20 v/v/v) were added in 10 ml sovirell tubes. The sealed
tubes were maintained at 70uC during 90 min. After cooling
0.1 ml 10% H2SO4 and 0.5 ml saturated solution of NaCl were
added and the solution diluted in 8 ml of pure n-hexane. FAME
were analysed by gas liquid chromatography on a Agilent 6890
apparatus fitted with cold ‘‘on-column’’ injection and a FID
detector (maintained at 250uC). The operating conditions were as
follows: 30 m60.25 mm, Factor four MAX from Varian, film
thickness: 0.25 mm; temperature programme: from 50uC (hold of
1 min) to 150uC at 30uC /min and from 150uC to 230 at 5uC /
min with a time final hold of 18 min. Helium at 70 KPa was used
as carrier gas. FAME were identified on the basis of their retention
time with those of the SUPELCO 37 FAME MIX (47885-U). The
results for each FAME are expressed in area %.
Western immunoblotting
Cell lysates were prepared with the use of RIPA buffer (10 mM
Tris [tris(hydroxymethyl)aminomethane], pH 7.4; 150 mM NaCl;
1% Triton 62100; 0.5% deoxycholate; 0.1% sodium dodecyl-
sulfate [SDS]; 5 mM ethylenediaminetetraacetic acid [EDTA])
containing protease inhibitors (complete tablets; Roche, Basel,
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Figure 1. Coculture of FLFCs and PCMDS for 48h: Influence on PCMDS. a PCMDS proliferation in direct contact (co) and in transwell (trw)
conditions with FLFCs and HS-5 stromal cell lines vs K562 and Jurkat cells in direct contact with FLFCs. **P,0.01 versus control cells (black columns)
(Student t test). Columns, mean of at least three independent determinations, bars. SD. b lipid accumulation was observed by Oil Red O staining in
PCMDS and in K562 in direct contact and in transwell condition (not show) but not in Jurkat cells (magnification, x20) shows intracytoplasmic
lipid droplets. c cell-cell direct contact with PCMDS induce morphological alterations in FLFCs that are not observed in transwell condition
(magnification, x20).
doi:10.1371/journal.pone.0025651.g001
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Switzerland). Aliquots of protein samples (50 mg) or equivalent
amounts of cells (26106 cells) were mixed with the same volume of
double-strength Laemmli buffer (125 mM Tris–HCl pH 6.8, 4%
SDS, 20% glycerol, 10% 2–mercaptoethanol, and 0.002%
bromophenol blue). The samples were boiled for 5 min and
subjected to SDS-polyacrylamide gel electrophoresis (PAGE) (7-
12% gradient gels). Immunobloting was performed using mono-
clonal antibodies or polyclonal antisera against actin (A 2066,
Sigma); BCL-2 (DAKO A/S, Glostrup, Denmark); leptin receptor
(R&D systems, France); AKT, Phospho-Akt (Ser473), (9272,
9271,respectively; Cell Signalling, Danvers, MA 01923). Immu-
nodetection was performed by the using of horseradish peroxidase-
Figure 2. Coculture of FLFCs and PCMDS: Leptin production and OB-R expression. a leptin production assessed by enzyme-linked
immunosorbent assay in direct contact (co) and transwell (trw) coculture of PCMDS with FLFCs or HS-5 stromal cell lines after one week (black
columns no contact; hatched columns direct end transwell contact). ***P,0.001 versus PCMDS in control condition (Student t test). b after 48h, leptin
receptor (OBR) expression was analysed by flow cytometry after immunostaining of PCMDS cultured in control conditions (black columns) or in co-
culture with FLFCs or HS-5 (hatched columns).*P,0.05 versus PCMDS in control condition (Student t test). Columns, mean of at least three
independent determinations, bars. SD.
doi:10.1371/journal.pone.0025651.g002
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conjugated secondary antibodies (mouse IgG or rabbit IgG,
horseradish peroxidase linked whole antibodies, NA931 or NA934,
Amersham, Buckinghamshire, UK) and an enhanced chemilumi-
nescence method (RPN2132; Amersham, Buckinghamshire, UK)
involving exposure to X-ray film (Amersham hyperfilm ECL,
Buckinghamshire, UK).
RNA extraction and Reverse Transcription-Polymerase
Chain Reaction Analysis
Total RNA was purified from cell suspensions using the High
Pure RNA Isolation kit (Roche Diagnostics, Germany). The
amount of purified RNA was quantified by fluorimetry using
the RiboGreenTM RNA Quantification kit (Molecular Probes
Eugene, USA). Those specific primers were used to amplify the
following mRNA: endogens 28S: 39-GTTCACCCACTAATAG-
GGAACGTGA and 59 GATTCTGACTTAGAGGCGTTCA-
GT OB-Rb: 59-GCCAACAACTGTGGTCTCTC and 39-AGA-
GAAGCACTTGGTGACTG; OB-Ra: 39-AAGGAGTGGGAA-
AACCAAAG and 59-CCACCATATGTTAACTCTCAG; Reac-
tions were performed in an automated thermal cycler (Perkin-
Elmer, USA) using the geneAmp Thermostable rTth Reverse
Transcriptase RNA PCR kit (Perkin-Elmer, USA), specific pairs of
primers (Eurogentec, Belgium), 10 ng of RNA per 25 ml reaction
mixture. Known copy number of the internal standard (ssRNA)
was used for 28S mRNA amplification.
Statistical analysis
Experiments were performed with at least three independent
determinations. The results were analyzed by independent
samples two-tailed and unpaired Student’s t-test, and were
presented as means 6 standard deviation (SD).
Results
Direct contact between FLFCs and PCMDS induced lipid
accumulation in PCMDS and inhibited their proliferation
It was previously shown that FLFCs obtained from BM
adipocytes exerted a negative control on granulocyte differentia-
tion [10]. This observation raised the question of wether FLFCs
influenced leukemic myelomonocytic cells. To address this issue,
FLFCs were cultured with a BCR-ABL positive myelomonocytic
leukemic cell line, PCMDS and HS-5 stromal cell line was used as
control. The co-cultures were realized either in direct contact or in
transwell conditions and stopped after 48 hours.
In both conditions, PCMDS proliferation rate as tested by [3H]
thymidine uptake was significantly (p,0.01) lower (3683.756
733.48 cpm) in the presence of FLFCs than in control conditions
(8678.561320.92 cpm) or in the presence of HS-5 (7829.56
462.79 cpm). This decrease in proliferation was also detected
with another BCR-ABL positive cell line, K562 cells (p,0.01)
(921.14668.04 cpm in control condition vs 614.716132.19 cpm
in co-culture with FLFC) but not with Jurkat cells (p = 0.184450)
(805.856142.73 cpm in control conditions vs 637.426107.14 cpm
in co-culture with FLFCs) (Fig. 1a). Cell survival was similar in all
the culture conditions tested (data not shown). Morphological
examination after Oil Red O staining showed that PCMDS and
K562 cells but not Jurkat cells accumulated lipid droplets in their
cytoplasm when co-cultured with FLFCs (Fig. 1b) but not with
HS-5 (not shown). Furthermore, when the co-cultures were
stopped after one week, morphological examination showed that,
in direct cell-cell contact, but not in transwell conditions, FLFCs
but not HS-5 displayed morphological alterations suggesting cell
death in the presence of PCMDS (Fig. 1c).
Contact between FLFCs and PCMDS induced leptin
production and increased OB-R expression on leukemic
cells
As adipocytes exert many effects on hematopoietic cells by
producing leptin [26], we have compared leptin production by
FLFCs and HS-5 and OB-R expression on the cell surface of
PCMDS in control (medium alone) and co-culture conditions
(Fig 2A and 2b). Leptin levels measured by Elisa in co-culture of
FLFCs with PCMDS in direct cell-cell contact were greatly
increased (p,0.001), compared to cultures of FLFCs alone
(344.68659.7 pg/ml vs 38.67643.67 pg/ml) or to co-culture of
FLFCs with CD34 progenitors (120 pg/ml) [10]. In transwell
conditions, leptin level (92.38617.26 pg/ml) was also significantly
increased (p,0.001) but to a lesser extent than in direct cell-cell
Table 1. Fatty acid composition of bone marrow aspirates
and biopsies.
Fatty acids Bone marrow aspirates Bone marrow biopsy







Fatty acids was analysed by gas lipid chromatography as described in ‘‘Materials
and methods’’. Values expressed as mean 6 SD (standard deviation)
doi:10.1371/journal.pone.0025651.t001
Figure 3. PCMDS in a medium supplemented with lipids
mixture for 24h. PCMDS viability (a) and proliferation (b) decrease
in contact with lipids (black columns no lipids stimulation; hatched
columns lipids stimulation). * P,0.05 and **P,0.01 versus PCMDS
without lipids treatment (Student t test). Columns, mean of at least
three independent determinations, bars. SD.
doi:10.1371/journal.pone.0025651.g003
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Figure 4. PCMDS, K562 and Jurkat cells cultured with stearic, oleic, linoleic and a-linolenic acids. a lipid accumulation in PCMDS, K562
and Jurkat cell in contact with saturated (SFA) and polyunsaturated (PUFA) fatty acids (magnification, x20 and x40) shows intracytoplasmic lipid
droplets. b effects of a-linolenic acid on PCMDS, K562 and Jurkat cells proliferation after 48 hours. *P,0.05 and ***P,0.001 versus in control
condition (Student t test). c effects of a-linolenic acid on PCMDS, K562 and Jurkat cells survival after 48 hours. **P,0.01 and ***P,0.001 versus in
control condition (Student t test). d effects of 200 mM of a-linolenic, linoleic, oleic and stearic acids on Bcl-2 expression (black columns no lipids
stimulation; hatched columns lipids stimulation) measured by western blot. *P,0.05 versus PCMDS in control condition (Student t test). e effects of
200 mM of a-linolenic, linoleic, oleic and stearic acids after 24 hours on OB-R (black columns) no lipids stimulation; hatched columns lipids stimulation)
Leptin and Fatty Acids Effects on Leukemics Cells
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e25651
contact. No leptin was detected in co-cultures of PCMDS with
HS-5.
OB-R expression was tested by flow cytometry. In control
condition, 21.63% of PCMDS expressed OB-R with a mean
fluorescence intensity of 25263.1. The percentage of PCMDS
expressing OB-R (p,0.05) as well as the fluorescence intensity
(p,0.05) greatly increased when they were co-cultured with
FLFCs but not with HS-5 (81.86611.16% and 446.3362 MFI
versus 3.3562.43% and 44.6 6 26.71 MFI) (Fig. 2b).
Lipid composition of normal bone marrow
As we observed lipid accumulation in PCMDS and K562
cytoplasm when they were cultured in contact with FLFCs, we
measured the lipidic content in four bone marrow biopsies and
two BM aspirates (Table 1). The total extractable lipid in the bone
marrow specimens varied between 19.4 to 35.2% of fresh tissue
weight. In BM biopsies, saturated fatty acids (SFA) accounted for
41.3364.6%, monounsaturated fatty acids (MUFA) for 48.386
4.11% and polyunsaturated acids (PUFA) for 5.7362.516% of the
total whereas in BM aspirates, SFA accounted for 36.2762.78%,
MUFA for 36.2869.41% and PUFA for 12.6960.5%.
Stearic saturated fatty acids (SFA), oleic
monounsaturated acid (MUFA) and linolenic
polyunsaturated fatty acids (PUFA) differentially
influenced PCMDS proliferation and survival, as well as
Bcl-2 and OB-R expression
The accumulation of lipids in myelomonocytic leukemic cells in
the presence of FLFCs led us to investigate wether the effects of
FLFCs were at least partially due to the fatty acids they contain.
To address this question, PCMDS were cultured in a medium
containing approximatively the same proportion (33%) of lipids
and the same composition (50% oleic, 43% stearic, 6.5% linoleic
and 0.5% a-linolenic acid) than that observed in a bone marrow
biopsy. After 48 hours, PCMDS viability and proliferation were
significantly decreased (95.1360.11% viability in control condi-
tions vs 91.7560.61% in the presence of lipids, p,0.05 and
1682661537.27 cpm in controls vs 8555.3361086.23 cpm in the
presence of lipids, p,0.01)(Fig.3a and 3b). To assess whether the
different types of fatty acids equally affected PCMDS survival and
proliferation, we cultured PCMDS, K562 and Jurkat cell lines in
presence of 50 to 250 mM of saturated stearic acids (SFA) or of
monounsaturated (MUFA) oleic acids or of polyunsaturated
(PUFA) linoleic acid and a-linolenic acids. This range of
concentration corresponded to that observed in situ. Lipid
accumulation in their cytoplasm was studied by Oil Red O
staining. In the presence of PUFA, PCMDS and K562
accumulated more lipids than in the presence of SFA. This
accumulation was also observed in Jurkat cells (Fig.4a). After
48 hours, a-Linolenic acid accumulation was associated with a
decrease of PCMDS and K562 proliferation (p,0.001)(100 mM:
1849.286304.33 cpm, 150 mM: 1189.576166.70 cpm, 200 mM:
763642.50 cpm and 250 mM: 394.14647.04 cpm vs 3301.716
603.50 cpm, in control) (150 mM: 6822.576587.42 cpm, 200 mM:
6569.856609.80 cpm and 250 mM: 4792.576280.26 cpm vs
12535.2861131.70 cpm, as control) and survival (p,0.001)
(150 mM: 23.4866.41%, 200 mM: 20.266.83% and 250 mM:
1.4360.32% vs 94.3161.59%, as control)(150 mM: 86.664.80%,
200 mM: 26.7627.01% and 250 mM: 2.8560.49% vs 97.860 as
control) in a dose dependant manner (Fig. 4b and 4c). Only high
amounts (250 mM) of a-linolenic acids slightly affected Jurkat cell
survival (p,0.01) (68.4665.22% vs 93.9360.35%) but without
any influence on their proliferation (Fig. 4b and 4c). Linoleic
(PUFA), oleic (MUFA) and stearic acids (SFA) did not affect
neither proliferation nor survival of PCMDS and K562 (results not
shown).
Linoleic (PUFA) and oleic acids (MUFA) did not influence Bcl-2
expression whereas, after 24 hours stearic acids (SFA) increased
(p,0.05) and a-linolenic acids (PUFA) decreased (p,0.05) its
expression in PCMDS (27326797 A.U. and 5086150 A.U.
respectively vs 1000 A.U. in control conditions) (Fig. 4d). The
decrease of Bcl-2 expression in presence of a-linolenic acids was
correlated to the low level of survival induced by this fatty acid
(Fig. 4b).
As BCR-ABL positive chronic myeloid leukemia cells express
leptin receptor (OB-R) [3] and as we observed an increase of OB-
R expression in PCMDS co-cultured with FLFCs, we evaluated
whether fatty acids could affect the expression of OB-R after
24 hours of culture. Our results showed that stearic, oleic and
linoleic fatty acids (200 mM) did not modify OB-R expression
(34.762.42% ; 25.9663.83% ; 22.0868.67%, respectively vs
27.1662.11% in control conditions). On the other hand, 200 mM
of a-linolenic acid induced a decrease of OB-R expression on
PCMDS surface after 24 hours (8.4860.79% vs 27.1662.11% in
control conditions) (P,0.001)(Fig. 4e).
Using RT-PCR analysis, we established that a-linolenic acid
(200 mM) decreased OB-Ra (p,0.05) and OB-Rb (p,0.05)
mRNA expression after 24 hours (76.5764.21 A.U and
54.14627.52 vs 100 A.U. in control conditions) whereas others
lipids analysed had no effect (Fig 4e).
Leptin alone did not influence PCMDS but inhibited the
effects of a-linolenic acid on PCMDS survival, Bcl-2 and
OB-R expression
The high levels of leptin in co-cultures of FLFCs and PCMDS led
us to analyse the effects of leptin on PCMDS cultured alone or in
presence of fatty acids. Leptin alone (300 pg/ml) did not influence
PCMDS proliferation, survival and OB-R expression. However,
leptin inhibited partially the decrease in OB-R expression induced by
a-linolenic acids (8.4860.79% with a-linolenic acid vs 18.8364.56%
with a-linolenic acid and leptin) (p,0.01)(p,0.05) (Fig. 5a). Leptin
also inhibited the decrease of BCL-2 expression induced by a-
linolenic acids (956.546231.21 vs 1000 A.U after 24 hours)(fig.5B),
maintained PCMDS survival in the presence of low concentrations of
a-linolenic acids (50 and 100 mM) and partially protected them from
death induced by the higher doses (150 mM to 250 mM) (p,0.05)
(150 mM : 90.460.55 vs 23.4866.41% , 200 mM: 85.562.47 vs
20.266.83 and 250 mM : 64.2660.90 vs 1.4360.32)(Fig.5c). Leptin
did not affected the decrease of proliferation induced by a-linolenic
acids (data not shown).
Low OB-R expression was associated with phospho-Akt
inhibition and caspase activation
Phosphatidylinositol 3-kinase (PI3K) was the main signalling
pathway of OB-R, implicated in the regulation of cell growth,
proliferation and apoptosis. After 24 hours of contact with a-
linolenic acids, a partial inhibition of Akt phosphorylation was
observed (p,0.01)(333 6 130 A.U vs 1000 A.U). Leptin addition
and on OB-Ra (black columns) and OB-Rb (hatched columns) mRNA expression in PCMDS. *P,0.05 and ***P,0.001 versus in control condition
(Student t test) Columns, mean of at least three independent determinations, bars. SD.
doi:10.1371/journal.pone.0025651.g004
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restored the activation of PI3K/AKT pathway (Fig. 6a). The low
level of phosphoAkt was associated with the low level of BCL-2
observed after 24 hours (Fig. 6b). As the antiapoptotic effect of
AKT is principally due to partial inhibition of caspase activation
[27–28], we used caspase inhibitor (R&D Systems Inc, France)
and showed a significant inhibition (p,0,05) of PCMDS cell
death induced by a-linolenic acid (85.2661.66 vs 77.0361.7%)
(Fig. 6c).
Figure 5. Leptin disturbed the effect of a-linolenic acids. a effect of 200 mM a-linolenic acids alone or with leptin (300pg/ml) on membranous
OB-R expression in PCMDS after 24 hours (black columns PCMDS without stimulation; hatched columns PCMDS with stimulation). OB-R expression
was analysed by flow cytometry. *P,0.05 and ***P,0.001 versus in control condition (Student t test). b effect of 200 mM a-linolenic acids alone or
with leptin (300pg/ml) on BCL-2 expression in PCMDS after 24 hours (black columns PCMDS without stimulation; hatched columns PCMDS with
stimulation) measured by western blot. *P,0.05 versus in control condition (Student t test). c effet of a-linolenic acids with or without leptin (300 pg/
ml) on PCMDS survival after 48 hours. *P,0.05 and ***P,0.001 versus in control condition (Student t test) Columns, mean of at least three
independent determinations, bars. SD.
doi:10.1371/journal.pone.0025651.g005
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Figure 6. a-Linolenic acid inhibit AKT phosphorylation and induce caspase activation. a Akt phosphorylation in PCMDS stimulated by a-
linolenic acid 24 hours with and without leptin (black columns PCMDS without stimulation; hatched columns PCMDS with stimulation) measured by
western blot. *P,0.05 versus in control condition. b PhosphoAkt (black columns) and BCL-2 (hatched columns) level in PCMDS after a-linolenic acid
contact with and without leptin. Akt phosphorylation and BCL-2 were measured by western blot. *P,0.05 versus in control condition (Student t
test).Columns, mean of at least three independent determinations, bars. SD. c PCMDS survival in control, with a-linolenic acid or with a-linolenic acid
and caspase inhibitor after 24 hours.
doi:10.1371/journal.pone.0025651.g006
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Discussion
Microenvironmental factors are suspected of influencing the
evolution of chronic myeloid leukemias (CML). In this work we
postulated that bone marrow adipocytes, leptin and lipids could be
involved.
In the first step, we analyzed in vitro the interactions between
adipocytes and two BCR-ABL positive cell lines using a T cell line
(Jurkat) and a stromal cell line (HS-5) as controls. Adipocytes
induced a decrease in BCR-ABL positive cell lines proliferation
but did not influence Jurkat cells. By contrast, HS-5 stromal cells
did not influence leukemic cells. This finding is in agreement with
previous studies reporting that CML cells proliferate continuously
even when being in contact with BM stroma [29]. In addition, it has
been shown that morphologically identifiable adipocytes, almost
absent in the bone marrow of leukemic patients [8,30] reappear in
high amounts during the remission period[13]. CML cell lines,
inducing adipocytes but not HS-5 cell death in vitro, could be
responsible for the disappearance of adipocytes observed in vivo [30].
In contact with adipocytes, leukemic cells of myeloid origin but
not of lymphoid origin accumulate lipids. This lipid accumulation
can be observed in vivo using Sudan Black B (SBB) staining [31].
Lipid accumulation in myeloid cells has previously been noted in
some pathological conditions such as atherosclerosis [32] and
asthma [33]. In cancer [18–19], this accumulation seems to
protect cells from microenvironmental cytotoxins [34–35] and to
induce inflammatory response [36–38] frequently observed in the
BM of CML patients [39] and associated with reduced
proliferation [34,40–41].
The consequences of lipid accumulation appear to be dependent
on the types of fatty acids accumulated. Our chromatographic
analyses of the BM aspirates and biopsies of healthy patients showed
a clear difference between the lipid composition of supernatant and
cells of the BM microenvironment .The supernatant were rich in
PUFA, while the cells were full of SFA and MUFA, fatty acids that
are generally accumulated by tumor cells to protect themselves
against external agents. An in vitro study has demonstrated that the
presence of adipocytes protects leukemia cells from chemothera-
peutic agents through Bcl-2 overexpression [42]. Our results
showed that stearic acid increased the Bcl-2 expression, whereas
others fatty acids (oleic and linoleic acids) had no effects. In contrast,
a-linolenic acid decreased BCL-2 and OB-R expression in CML
cell lines and reduced the proliferation and the survival of these cell
lines. These observations are in direct agreement with two studies
realised in HL-60 (Human promyelocytic leukemia cells) and U937-
1 (Human monocytic cell line) cell lines where EPA (Eicosapentae-
noic acid), a derivative of a-linolenic acid, once accumulated in the
cell, reduced survival and proliferation [40–41]. Other studies
focusing on breast cancer also showed an apoptotic and
antiproliferative effects of omega-3 polyunsaturated fatty acids
(PUFAs n-3) including a-linolenic acid [18,43]. These findings are
consistent with a study that showed that a cell with PUFAs n-3 was
more sensitive to chemotherapy than the one filled with oleic and
stearic acid [19].
This phenomenon seems to be specific to the myeloid lineage.
Indeed, the majority of T-cell lines, previously characterized as
Sudan Black B negative [31], do not accumulate fat. But some
studies presented rare cases of SBB positive acute lymphoblastic
leukemia (ALL) [44] as the Jurkat T cell line [45]. This rare
occurrence might explain why small lipids droplets are observed in
contact with PUFA. But unlike Cury-Boaventura et al, in our study
we did not observe any effect of fatty acid on Jurkat cells
proliferation and survival [46]. The reason of this discrepancy
might be the presence of antioxydant in our culture medium.
Although the fish omega-3 fatty acids protective role against
cancer is known, the role of a-linolenic acid, a PUFA n-3 found in
high concentrations in vegetable oils, 5 to 10 times more prevalent
[43] in the diet, remains controversial. a-Linolenic acid protects
against atherosclerosis, a disease involving monocytes which
accumulate fat and generate foam cells [47]. The effect of a-
linolenic acid on increasing the risk of prostate cancer is still
debated [47,48].
According to different studies in tumor cells [49–50], the effects
of a-linolenic acids in myeloid leukemia seemed to be directly
related to PI3K pathway and Bcl-2 inhibition associated with
caspase activation. Fatty acids act on normal or tumor cells via this
pathway. PUFA n-3 inhibits, while PUFA n-6 and MUFA
activate, the PI3K pathway [4,18]. The PI3K pathway is activated
in many cancers [3,51–52] and is linked to the control of growth,
migration, proliferation and apoptosis of tumor cells such as
leukemic cells [3–4,34]. This pathway is essential for the survival of
leukemic cells [50] and is involved in the development of resistance
to treatment with imatinib [22].
In our study, we have also shown that leptin production was
increased when BCR-ABL positive cell lines were co-cultured with
adipocytes. Leptin is known as a proliferative and antiapoptotic
agent in many cancers [23,51,53]. According to recent studies, the
effects of leptin involve its receptor (OB-R) and PI3K pathway
[27,54], the major signaling pathway of OB-R [21]. In our study,
leptin alone had no effect on OB-R expression, proliferation or
survival of CML. This might be explained by the difference in the
amount of leptin used. Identical amounts to those observed in the
co-culture medium were used, i.e. 300 pg / ml, whereas in others
studies, the concentration of leptin used was about 30 to 3000 fold
higher [53–54].
However, in the presence of leptin, the effects of a-linolenic acid
on proliferation, survival, OB-R and BCl-2 were reduced. This
phenomenon was also observed, after the addition of DHA
(Docosahexaenoic acid), an other derivative of a-linolenic acid, in
the presence and absence of leptin in rat glial and pituitary cells
tumor [55]. Both our results and previous studies suggest that an
adipocyte-rich composition of stearic and oleic acid promotes the
development of leukemia, while a-linolenic acid exerts an inhibitory
effect. Leptin can counteract a-linolenic acid inhibitory effects.
Therefore we suggest that at the onset of the disease, bone
marrow adipocytes partially inhibited the expression of malignant
leukemic clone. Cytokines produced by leukemic cells induce
lipolysis of BM adipocytes. Then PUFA n-3 released from the
adipocytes impairs CML proliferation and survival by inhibiting
the PI3K pathway. Thereafter, these effects are soon inhibited by
leptin released by adipocytes that also increased the lipolysis of
adipocytes [56] releasing SFA and MUFA that protect CML from
apoptosis by activating the PI3K pathway. A fat cell that loses its
fat is destined to die [56–57]. This could explain why adipocytes
are suffering in contact with CML and why adipocytes almost
disappear in CML [30]. Then, in blast crisis, leukemic cells
proliferate and survive without any influence by adipocytes, but
under the influence of lipids supplied from blood LDL. After
treatment, the reappearance of adipocytes could influence the
survival of some residual malignant cells.
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